MORRISVILLE, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the ...
The team found that for every standard deviation decrease in the thickness of the photoreceptor layer of the retina, the risk of non-hypertensive congestive heart failure increases by 25%, chronic ...
China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...
In her introduction, Karadogan noted that a significant proportion of patients with chronic lung diseases continue to smoke tobacco even after being diagnosed with their condition. In the U.S., 38% of ...